NOMINATION AND STANDSTILL AGREEMENTNomination and Standstill Agreement • February 21st, 2014 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 21st, 2014 Company Industry JurisdictionThis NOMINATION AND STANDSTILL AGREEMENT (the “Agreement”) is made as of February 20, 2014 by and among ARIAD Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the persons and entities listed on Schedule A hereto (collectively, the “Sarissa Group”). In consideration of the covenants and promises set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:
NOMINATION AND STANDSTILL AGREEMENTNomination and Standstill Agreement • February 21st, 2014 • Sarissa Capital Management LP • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 21st, 2014 Company Industry JurisdictionThis NOMINATION AND STANDSTILL AGREEMENT (the “Agreement”) is made as of February 20, 2014 by and among ARIAD Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the persons and entities listed on Schedule A hereto (collectively, the “Sarissa Group”). In consideration of the covenants and promises set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows: